These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12066789)

  • 1. Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fc gamma RIIIa alters the interaction with anti-CD20 monoclonal antibody.
    Oshima Y; Fujimura A
    Blood; 2002 Jun; 99(12):4649; author reply 4650. PubMed ID: 12066789
    [No Abstract]   [Full Text] [Related]  

  • 2. The N-linked oligosaccharide at Fc gamma RIIIa Asn-45: an inhibitory element for high Fc gamma RIIIa binding affinity to IgG glycoforms lacking core fucosylation.
    Shibata-Koyama M; Iida S; Okazaki A; Mori K; Kitajima-Miyama K; Saitou S; Kakita S; Kanda Y; Shitara K; Kato K; Satoh M
    Glycobiology; 2009 Feb; 19(2):126-34. PubMed ID: 18952826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.
    de Haas M; Koene HR; Kleijer M; de Vries E; Simsek S; van Tol MJ; Roos D; von dem Borne AE
    J Immunol; 1996 Apr; 156(8):2948-55. PubMed ID: 8609432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.
    Stopforth RJ; Cleary KL; Cragg MS
    J Clin Immunol; 2016 May; 36 Suppl 1():88-94. PubMed ID: 26922075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic linkage of Fc gamma RIIa and Fc gamma RIIIa and implications for their use in predicting clinical responses to CD20-directed monoclonal antibody therapy.
    Hatjiharissi E; Hansen M; Santos DD; Xu L; Leleu X; Dimmock EW; Ho AW; Hunter ZR; Branagan AR; Patterson CJ; Kortsaris A; Verselis S; Fox E; Treon SP
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):286-90. PubMed ID: 17324336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.
    Wilson NS; Yang B; Yang A; Loeser S; Marsters S; Lawrence D; Li Y; Pitti R; Totpal K; Yee S; Ross S; Vernes JM; Lu Y; Adams C; Offringa R; Kelley B; Hymowitz S; Daniel D; Meng G; Ashkenazi A
    Cancer Cell; 2011 Jan; 19(1):101-13. PubMed ID: 21251615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding epitopes of human CD16 (Fc gamma RIII) monoclonal antibodies. Implications for ligand binding.
    Tamm A; Schmidt RE
    J Immunol; 1996 Aug; 157(4):1576-81. PubMed ID: 8759741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain swap chimeras to study the binding of IgG by Fc gamma RI, the high affinity receptor for IgG.
    Harrison PT; Allen JM
    Biochem Soc Trans; 1996 Feb; 24(1):144S. PubMed ID: 8674636
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism.
    Haagen IA; Geerars AJ; Clark MR; van de Winkel JG
    J Immunol; 1995 Feb; 154(4):1852-60. PubMed ID: 7836769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction.
    Kanakaraj P; Duckworth B; Azzoni L; Kamoun M; Cantley LC; Perussia B
    J Exp Med; 1994 Feb; 179(2):551-8. PubMed ID: 8294866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand.
    Raghavan M; Chen MY; Gastinel LN; Bjorkman PJ
    Immunity; 1994 Jul; 1(4):303-15. PubMed ID: 7889418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
    Musolino A; Naldi N; Bortesi B; Pezzuolo D; Capelletti M; Missale G; Laccabue D; Zerbini A; Camisa R; Bisagni G; Neri TM; Ardizzoni A
    J Clin Oncol; 2008 Apr; 26(11):1789-96. PubMed ID: 18347005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides from mouse Fc receptor (MoFc gamma RII) that alter the binding of IgG to MoFc gamma RII.
    Goldsmith EB; Erickson BW; Thompson NL
    Biochemistry; 1997 Jan; 36(4):952-9. PubMed ID: 9020795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of red cells by monoclonal IgG3 anti-D in vivo is affected by the VF polymorphism of Fcgamma RIIIa (CD16).
    Kumpel BM; De Haas M; Koene HR; Van De Winkel JG; Goodrick MJ
    Clin Exp Immunol; 2003 Apr; 132(1):81-6. PubMed ID: 12653840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation.
    Azzoni L; Kamoun M; Salcedo TW; Kanakaraj P; Perussia B
    J Exp Med; 1992 Dec; 176(6):1745-50. PubMed ID: 1281217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of FcR Ig-binding sites and epitope mapping.
    Hogarth PM; Ierino FL; Hulett MD
    Immunomethods; 1994 Feb; 4(1):17-24. PubMed ID: 7520815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.